UPDATED December 18, 2020: As the release of the first vaccine for COVID-19 this week indicates a promising future for gathering together, the recent surge in infection rates and the uncertainty of when gathering will be safe, AATOD has concluded that we need to plan for an all-virtual conference event rather than a hybrid model to protect the health of conference participants and stabilize our ability to plan for an effective and content rich conference experience. Rest assured, as we transition to an all-virtual conference, AATOD will continue to provide the world’s premier training and education event for the treatment of opioid use disorder.
Forging Partnerships to Improve Access to Quality Care
- To discuss the latest research and regulatory developments relevant to the field of medication assisted treatment and critically evaluate the implications in managing the opioid epidemic;
- To disseminate innovative and evidence-based initiatives designed to increase access to services, improve program development and administration, and enhance patient outcomes;
- To strategize approaches to promote, support, facilitate, and integrate medication assisted treatment into the judicial and penal systems, government, social service organizations, and mainstream medicine;
- To identify and promote strategies that assist healthcare partnerships and collaborations by advancing understanding and acceptance of medication assisted treatment as a crucial element to community wellness and response to the opioid epidemic; and
- To address and refute misinformation and stigma and promote acceptance of comprehensive medication assisted treatment throughout the continuum of care.
The American Association for the Treatment of Opioid Dependence, Inc.
and the 2021 Conference Planning Committee acknowledge and give special thanks to:
Department of Health and Human Services Nevada Division of Public and Behavioral Health (DPBH)